Home / Compliance actions / 691860

FDA Warning Letter — Roselawn Marathon

Case 691860 — FEI 3014329564

The FDA took a Warning Letter action against Roselawn Marathon on Sep 5, 2024 (Cincinnati, OH). The action was issued by CTP and concerns tobacco products.

Action Details

Facility
Roselawn Marathon
Date
Sep 5, 2024
Fiscal Year
2024
Product Type
Tobacco
Center
CTP
Location
Cincinnati, OH (United States)

Facility

Other compliance actions

FDA data resources

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.